| PACKAGING TYPE: | Alu-alu |
| COMPOSITION: | Each Film Coadted Bilayered Tablet Contains : Dapagliflozin Propanediol Monohydrate Usp Eq To Dapagliflozin 5mg , Vildagliptin Ip (sustained Release ) 100mg |
| FORMULATION: | Tablets |
| Description: | VIDASAFE D 100/5 Tablets are bilayered film-coated tablets combining Dapagliflozin 5 mg and Vildagliptin 100 mg (Sustained Release). Designed to help manage blood sugar levels in adults with type 2 diabetes, these tablets work by reducing glucose reabsorption in kidneys and improving insulin secretion. Suitable for use under medical supervision, this combination therapy aids in maintaining healthy glycemic control. |
| Side Effects: | Mild urinary tract infections Increased urination or thirst Headache or dizziness Gastrointestinal discomfort (nausea, stomach upset) |
| Precaution: | Use only as prescribed by a healthcare professional Monitor blood sugar regularly to avoid hypoglycemia Inform your doctor if you have kidney or liver disease Avoid dehydration; maintain adequate fluid intake Not recommended for type 1 diabetes or during pregnancy |
| Product Benefits: | Helps control blood sugar levels effectively in type 2 diabetes patients Supports insulin secretion and reduces glucose absorption from kidneys Convenient bilayered tablet with sustained release for long-lasting effect Can be used as part of a diet and |











